Bloomage Biotechnology Corp Ltd (688363) - Total Liabilities
Based on the latest financial reports, Bloomage Biotechnology Corp Ltd (688363) has total liabilities worth CN¥1.59 Billion CNY (≈ $232.72 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Bloomage Biotechnology Corp Ltd (688363) asset resilience to evaluate the company's liquid asset resilience ratio.
Bloomage Biotechnology Corp Ltd - Total Liabilities Trend (2012–2025)
This chart illustrates how Bloomage Biotechnology Corp Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Bloomage Biotechnology Corp Ltd total assets.
Bloomage Biotechnology Corp Ltd Competitors by Total Liabilities
The table below lists competitors of Bloomage Biotechnology Corp Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Warby Parker Inc
NYSE:WRBY
|
USA | $380.33 Million |
|
Pharvaris BV
NASDAQ:PHVS
|
USA | $27.86 Million |
|
Sumitomo Chemical India Limited
NSE:SUMICHEM
|
India | Rs12.37 Billion |
|
KCE Electronics Public Company Limited
BK:KCE
|
Thailand | ฿4.73 Billion |
|
Visteon Corp
NASDAQ:VC
|
USA | $1.74 Billion |
|
Four Corners Property Trust Inc
NYSE:FCPT
|
USA | $1.37 Billion |
|
Mivne Real Estate KD Ltd
TA:MVNE
|
Israel | ILA12.09 Billion |
|
Rogers Corporation
NYSE:ROG
|
USA | $233.80 Million |
Liability Composition Analysis (2012–2025)
This chart breaks down Bloomage Biotechnology Corp Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Bloomage Biotechnology Corp Ltd net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.36 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bloomage Biotechnology Corp Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bloomage Biotechnology Corp Ltd (2012–2025)
The table below shows the annual total liabilities of Bloomage Biotechnology Corp Ltd from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.58 Billion ≈ $230.82 Million |
-13.19% |
| 2024-12-31 | CN¥1.82 Billion ≈ $265.87 Million |
+22.22% |
| 2023-12-31 | CN¥1.49 Billion ≈ $217.53 Million |
-25.63% |
| 2022-12-31 | CN¥2.00 Billion ≈ $292.48 Million |
+10.96% |
| 2021-12-31 | CN¥1.80 Billion ≈ $263.58 Million |
+189.28% |
| 2020-12-31 | CN¥622.68 Million ≈ $91.12 Million |
+47.52% |
| 2019-12-31 | CN¥422.11 Million ≈ $61.77 Million |
+19.39% |
| 2018-12-31 | CN¥353.56 Million ≈ $51.74 Million |
+44.10% |
| 2017-12-31 | CN¥245.35 Million ≈ $35.90 Million |
-42.07% |
| 2016-12-31 | CN¥423.53 Million ≈ $61.98 Million |
-57.95% |
| 2015-12-31 | CN¥1.01 Billion ≈ $147.39 Million |
+373.01% |
| 2014-12-31 | CN¥212.94 Million ≈ $31.16 Million |
+4.40% |
| 2013-12-31 | CN¥203.96 Million ≈ $29.85 Million |
+109.65% |
| 2012-12-31 | CN¥97.29 Million ≈ $14.24 Million |
-- |
About Bloomage Biotechnology Corp Ltd
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers beauty and care products under brand Hymagic-VCHA VC Hylauronic Acid; Biomeet-MarineDNA; Bioyouth-SPG Schizophyllan Gel; Hymagic-GluHA; Bloomsurfact EncapCare RP; Bloomsurfact Sodium Surfactin; Hybloom Minitrue; Bioyouth-EGT Pure Ultrapure Ergothioneine; miniHA HA-Oligo degraded by… Read more